Balaxi Pharmaceuticals Ltd.

₹20.33

0.1 (0.6%)

BALAXI Share Price

Pharmaceuticals & Biotechnology

As on October 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 112.24 Cr

P/E Ratio21.81

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	20.43	Bearish
10-DMA	21.14	Bearish
20-DMA	21.82	Bearish
50-DMA	22.71	Bearish
100-DMA	23.3	Bearish
200-DMA	23.31	Bearish

Historical Performance

1 Year

-51.2%

3 Years

-75.9%

5 Years

-81.3%

10 Years

539.3%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	2,702	2,926	2,413	3,364	2,794
Total Expenditure	2,606	2,603	1,968	2,790	2,286
Other Income	28	24	6	26	50
Operating Profit	124	346	452	601	558
Interest	50	40	28	14	8
Depreciation	22	19	21	18	5
Profit Before Tax	53	287	20	569	545
Consolidated Net Profit	173	277	-73	517	482
Adjusted EPS	3	5	-1	10	10

Compounded Sales Growth

10 Years:342.8

5 Years:-1.4

3 Years:-5.7

TTM:5.8

Compounded Profit Growth

10 Years:85.9

5 Years:-19.4

3 Years:-20.5

TTM:7.4

Stock Price CAGR

10 Years:20.4

5 Years:-28.9

3 Years:-37.8

TTM:-51.7

Return on Equity

10 Years:-0.1

5 Years:2.9

3 Years:0.7

last year:0.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	110	110	109	102	100
Total Reserves	2,380	2,207	1,867	1,624	1,032
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	258	241	28	37	---
Other Current Liabilities	54	46	46	28	33
Short Term Borrowings	334	304	177	108	36
Total Liabilities	3,370	3,103	2,583	2,397	1,765
Capital Work in Progress	---	221	23	28	6
Long Term Loans & Advances	35	41	46	15	13
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	111	112	80	42	37
Total Current Assets	2,514	2,428	2,102	1,935	1,410
Total Assets	3,370	3,103	2,583	2,397	1,765
Adjusted Book Value	45	42	36	34	113

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 21.81, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a weak 3-year price CAGR of -37.3%, indicating poor shareholder returns.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹107 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹809 million, indicating a relatively small business scale.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 483242.2

No. of Shares: 23770 (Approx)

Performance:-51.7%

-516757.8

NIFTY Performance: -12.9%

1 day Top Gainers